Improving Maternal and Neonatal Care-seeking Through a Video-informed Training Session During the Third Trimester of Pregnancy (Taabo T3)
14 september 2026 uppdaterad av: Swiss Tropical & Public Health Institute
Improving Maternal and Neonatal Care-Seeking Through a Video-Informed Training Session During the Third Trimester of Pregnancy
This study is a randomized controlled trial evaluating the impact of a video-informed training session on maternal and newborn health care seeking in rural Côte d'Ivoire.
Studieöversikt
Status
Har inte rekryterat ännu
Betingelser
Intervention / Behandling
Detaljerad beskrivning
In Taabo, Côte d'Ivoire, many women do not receive recommended care during the third trimester of pregnancy or the early postpartum period, contributing to adverse maternal and neonatal health outcomes.
In this individual-level open-label randomized controlled trial, we will evaluate the impact of an information and planning intervention on timely care-seeking during the third trimester of pregnancy and the early postpartum period.
The study will enroll 800 women who are currently in the third trimester of pregnancy and randomize them to one of two groups: (1) control, or (2) information video and planning session for the pregnant women and her partner.
A baseline survey will be performed at the time of enrollment, and outcomes will be evaluated using an endline survey 6-8 weeks after the end of pregnancy.
The main outcome of the study is the number of health care contacts that women have between enrollment in the study and 6 weeks postpartum.
Studietyp
Interventionell
Inskrivning (Beräknad)
800
Fas
- Inte tillämpbar
Kontakter och platser
Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.
Studieorter
-
-
-
Taabo, Côte d’Ivoire
- Centre Suisse de Recherches Scientifiques en Cote d'Ivoire
-
Kontakt:
- Siaka Koné, PhD
- Telefonnummer: +2250749069627
- E-post: Siaka.kone@csrs.ci
-
-
Deltagandekriterier
Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.
Urvalskriterier
Åldrar som är berättigade till studier
- Barn
- Vuxen
- Äldre vuxen
Tar emot friska volontärer
Nej
Beskrivning
Inclusion Criteria for Pregnant Women:
- Currently pregnant
- Aged 15 years or older
- Live in the area served by the Taabo Health & Demographic Surveillance System
- Estimated gestational age between 6 completed months of pregnancy and 8 completed months of pregnancy
Inclusion Criteria for Male Partners:
- Aged 15 or older
- Married to or currently the main romantic partner of a woman who is enrolled in the study
Studieplan
Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Hälsovårdsforskning
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Inget ingripande: Control group
This group will not receive any intervention.
|
|
|
Experimentell: Information Video and Planning Session group
This group will receive the study intervention, including an information video and planning session for the pregnant woman and her partner.
|
The study intervention is a video-informed information and planning session for health care during the third trimester, childbirth, and the first six weeks postpartum.
In this intervention, a member of the study team will show information videos to pregnant women and her partner, summarizing key recommendations for health and health care seeking during the third trimester of pregnancy and the first six weeks following childbirth.
After showing the videos, the study team member will guide the pregnant woman and her partner in a short discussion about planning for care-seeking during the third trimester and early postpartum period.
This discussion will include quizzing on the content of the information videos and discussions of care-seeking plans together with the couple.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Number of health care contacts as reported by women during endline survey
Tidsram: From enrollment to 6 weeks postpartum (measured 6-8 weeks after the end of pregnancy)
|
Number of health care contacts that women have between enrollment in the study and 6 weeks postpartum, including antenatal care visits, childbirth, and postpartum care visits
|
From enrollment to 6 weeks postpartum (measured 6-8 weeks after the end of pregnancy)
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Number of antenatal care visits as reported by women during endline survey
Tidsram: Between enrollment and the end of pregnancy (measured 6-8 weeks after the end of pregnancy)
|
Number of antenatal care visits
|
Between enrollment and the end of pregnancy (measured 6-8 weeks after the end of pregnancy)
|
|
Facility-based childbirth as reported by women during endline survey
Tidsram: Measured 6-8 weeks after the end of pregnancy
|
Proportion of women who gave birth in a health facility
|
Measured 6-8 weeks after the end of pregnancy
|
|
Number of postpartum visits as reported by women during endline survey
Tidsram: From the end of pregnancy to 6 weeks postpartum (measured 6-8 weeks after the end of pregnancy)
|
Number of postpartum care visits between the end of pregnancy and 6 weeks postpartum
|
From the end of pregnancy to 6 weeks postpartum (measured 6-8 weeks after the end of pregnancy)
|
|
Fetal movement counting as reported by women during endline surveys
Tidsram: Measured 6-8 weeks after the end of pregnancy
|
The proportion of pregnant women who report counting fetal movements at least once during the final month of their pregnancy
|
Measured 6-8 weeks after the end of pregnancy
|
|
Perinatal mortality as reported by women during endline surveys
Tidsram: Measured 6-8 weeks after end of pregnancy
|
The proportion of women who experience a stillbirth or neonatal death in the first seven days of life (perinatal mortality)
|
Measured 6-8 weeks after end of pregnancy
|
|
Neonatal mortality as reported by women during endline surveys
Tidsram: Measured 6-8 weeks after end of pregnancy
|
The proportion of women whose child dies in the first 28 days of life
|
Measured 6-8 weeks after end of pregnancy
|
|
Average care-seeking knowledge scores among pregnant women and their partners
Tidsram: Measured 6-8 weeks after the end of pregnancy
|
Average scores (among pregnant women and their partners) on assessments of knowledge of care-seeking recommendations during the third trimester and the early postpartum period, as measured using five questions during endline surveys with pregnant women and their partners. We create a Care-Seeking Knowledge Scale as follows: Participants receive 1 point if they respond with 3 or more when asked how many postpartum visits women should have during the first 6 weeks after childbirth; 1 point if they correctly name at least 3 danger signs for women during pregnancy; 1 point if they correctly name at least 3 danger signs for women during the first six weeks after childbirth; and 1 point if they correctly name at least 3 danger signs for newborns. Scores range from 0 to 4 with higher scores representing greater knowledge. |
Measured 6-8 weeks after the end of pregnancy
|
Samarbetspartners och utredare
Det är här du hittar personer och organisationer som är involverade i denna studie.
Samarbetspartners
Studieavstämningsdatum
Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.
Studera stora datum
Studiestart (Beräknad)
1 september 2026
Primärt slutförande (Beräknad)
1 maj 2027
Avslutad studie (Beräknad)
1 maj 2027
Studieregistreringsdatum
Först inskickad
8 september 2026
Först inskickad som uppfyllde QC-kriterierna
8 september 2026
Första postat (Faktisk)
14 september 2026
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
17 september 2026
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
14 september 2026
Senast verifierad
1 september 2026
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 2026-19
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
JA
IPD-planbeskrivning
De-identified data files and analytic code will be posted on public repositories at the time of publication of results.
Tidsram för IPD-delning
We plan to share IPD and supporting information at the time of publication.
Kriterier för IPD Sharing Access
IPD and supporting information will be made available on public repositories.
IPD-delning som stöder informationstyp
- STUDY_PROTOCOL
- SAV
- ICF
- ANALYTIC_CODE
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Nej
Studerar en amerikansk FDA-reglerad produktprodukt
Nej
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .